Titan America SA Common Shares (TTAM)
17.36
-0.71 (-3.93%)
NYSE · Last Trade: Feb 1st, 4:53 AM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025

